Soy isoflavone metabolism in cats compared with other species: urinary metabolite concentrations and glucuronidation by liver microsomes

Abstract

1. Soybean is a common source of protein in many pet foods. Slow glucuronidation of soy-derived isoflavones in cats has been hypothesized to result in accumulation with adverse health consequences. Here, we evaluated species’ differences in soy isoflavone glucuronidation using urine samples from cats and dogs fed a soy-based diet and liver microsomes from cats compared with microsomes from 12 other species.

2. Significant concentrations of conjugated (but not unconjugated) genistein, daidzein and glycitein, and the gut microbiome metabolites, dihydrogenistein and dihydrodaidzein, were found in cat and dog urine samples. Substantial amounts of conjugated equol were also found in cat urine but not in dog urine.

3. β-Glucuronidase treatment showed that all these compounds were significantly glucuronidated in dog urine while only daidzein (11%) and glycitein (37%) showed any glucuronidation in cat urine suggesting that alternate metabolic pathways including sulfation predominate in cats.

4. Glucuronidation rates of genistein, daidzein and equol by cat livers were consistently ranked within the lowest 3 out of 13 species’ livers evaluated. Ferret and mongoose livers were also ranked in the lowest four species.

5. Our results demonstrate that glucuronidation is a minor pathway for soy isoflavone metabolism in cats compared with most other species.

• Cat
• daidzein
• dog
• equol
• genistein
• glucuronidation
• isoflavone
• soy

Acknowledgements

The authors would like to acknowledge Keith Dan DVM who contributed to this work under the sponsorship of the Agnes Varis Research Scholars program while a student at Tufts University Cummings School of Veterinary Medicine.

Declaration of interest

This work was also supported by the US National Institutes of Health grant (GM102130 to M.H.C.), the William R. Jones endowment to Washington State University College of Veterinary Medicine (to M.H.C.). Dr Shrestha was supported by a Fulbright Scholarship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. Normal human liver samples were obtained through the Liver Tissue Cell Distribution System, Minneapolis, MN and Pittsburgh, PA, which was funded by NIH Contract No. N01-DK-7-0004/HHSN267200700004C.